“Benzodiazepines are a class of medication with sedative properties, commonly used for anxiety and other neurological conditions. These medications are associated with several well-known adverse effects.
This observational study aims to investigate the reduction of benzodiazepine use in patients using prescribed medical cannabis.
Within a cohort of 146 patients initiated on medical cannabis therapy, 45.2% patients successfully discontinued their pre-existing benzodiazepine therapy.
Medical cannabis remains a controversial but potentially effective treatment for patients suffering from a variety of medical conditions. Within a cohort of patients initiated on medical cannabis therapy, a large proportion successfully discontinued their pre-existing benzodiazepine therapy.
This study therefore supports the continued research of medical cannabis and urges further exploration into its therapeutic value.”
https://www.liebertpub.com/doi/10.1089/can.2018.0020